ERBB2 and neoplasm: To derive sufficient information from the entire tumor in a non-invasive way, our study used different machine learning algorithms combining distinct radiomics feature sets to find the optimal models to differentiate TNBC vs. non-TNBC, HER2+ vs. HER2−, and HR+/HER2− vs. others, and achieved excellent performance.